+
  • 图片 10.png

1-Cyclopropyl-6, 7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester


112811-71-9

Standardized and sophisticated testing instruments and a high-quality workforce have created a large domestic production base of gatifloxacin; the technical advantages and production scale of perindopril tert-butylamine salt intermediate indoline-2-carboxylic acid series products are also among the best at home and abroad, with a good reputation.


Product Details


Chinese name: 1-cyclopropyl-6, 7-difluoro-1, 4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester
English Name:1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid ethyl ester
Cas No.:112811-71-9
Structural formula:
Molecular formula: C16H15F2NO4
Product Description: This product is the intermediate of gatifloxacin.
Technical indicators:

Project Standard
Traits White-like crystalline powder
Content ≥ 98.5%
single impurity ≤0.5%
Related substances ≤ 1.0%
Melting Point 182~186 ℃
loss on drying ≤0.5%
residue on ignition ≤0.2%

Packing: 25kg cardboard drum, lined with double plastic bags
Storage and transportation: shading, sealing, stored in a dry place, the storage period is two years.

Standardized and sophisticated testing instruments and a high-quality workforce have created a large domestic production base of gatifloxacin; the technical advantages and production scale of perindopril tert-butylamine salt intermediate indoline-2-carboxylic acid series products are also among the best at home and abroad, with a good reputation. Four of these APIs have passed the national GMP certification, and two other APIs are under approval. The company has two major advantages of reaction: 1. high pressure hydrogenation reaction; 2. enzyme catalytic reaction.


Related Products


Message consultation